Renowned Dalhousie scientist to release major findings from CNIB-funded
study, providing hope to 67 million affected by glaucoma worldwide
MONTREAL, June 21 /CNW/ - A Dalhousie University scientist is releasing
results from Canada's largest ever clinical study into glaucoma tomorrow. The
far-ranging investigation, which included participation from five
hospital-based universities from across the nation, is entitled "The Canadian
Glaucoma Study (1992-2007): Risk Factors for the Progression of Open Angle
Glaucoma, First Report of Results."
Results will be presented at the annual scientific meeting of the
Canadian Ophthalmological Society (COS) in Montreal. Lead investigator
Dr. Balwantray Chauhan, Chair in Vision Research at the Department of
Ophthalmology and Visual Sciences of Dalhousie University, will be joined by
members of his research team to present four major breakthroughs. Since the
study was primarily funded by $1.8 million in research grants from CNIB,
President and CEO Jim Sanders (who himself has glaucoma), as well as Dr. Keith
Gordon, CNIB Head of Research, will also be on hand.
The results will have an enormous impact across the nation, since almost
250,000 Canadians have open-angle glaucoma. Half of those affected are unaware
because the disease typically progresses unnoticed until vision loss is
When: Friday, June 22 at 11:00 a.m.
Media Presentation: In the Peribonka Room
Where: Fairmont Queen Elizabeth Hotel
900 Réné-Levesque Blvd. W., Montreal.
Note: Reporters must check in at the registration desk upon arrival.
For further information:
For further information: Sylvain-Jacques Desjardins, Communications
Manager, CNIB, Office: (514) 934-4622, ext. 227, Cellular: (514) 247-7383,
email@example.com; Joyce Davis, Media officer, COS, Cellular:
(613) 794-3138, firstname.lastname@example.org